OncoNext™ Risk Melanoma is a diagnostic test, developed by GENOMA Group, which allows you to perform a multiple genetic analysis to assess the predisposition to the development of Melanoma. The test, therefore, allows you to identify patients at risk of developing this neoplasia by analyzing their DNA.